drugset / Trial / NCT00885690

Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA)

NCT00885690

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Cognition is one of the core symptoms of schizophrenia. This study is a head-to-head trial between olanzapine and sertindole with cognition as primary outcome. The design is a 12-week double-blinded randomized controlled flexible dose study.

Timeline

Start
2009-04
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Olanzapine Small molecule 10 mg
Comparator Olanzapine Small molecule 20 mg
Comparator Sertindole Small molecule 16 mg
Comparator Sertindole Small molecule 24 mg

Indications